INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summarized Statements of Operations of Unconsolidated Entities Accounted by Equity Method (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
Schedule of Equity Method Investments [Line Items] | ||||
TMHC’s share in income of unconsolidated entities | $ 2,514 | $ 2,787 | $ 9,777 | $ 6,943 |
Equity Method Investments | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Revenues | 95,085 | 60,020 | 264,624 | 147,273 |
Costs and expenses | (84,409) | (47,505) | (227,061) | (118,546) |
Income of unconsolidated entities | 10,676 | 12,515 | 37,563 | 28,727 |
TMHC’s share in income of unconsolidated entities | 2,514 | 2,787 | 9,777 | 6,943 |
Distributions from unconsolidated entities | $ 13,176 | $ 2,098 | $ 26,439 | $ 8,889 |
X | ||||||||||
- Definition Proceeds From Equity Method Investment, Dividends Or Distributions And Return Of Capital No definition available.
|
X | ||||||||||
- Definition The amount of the cost of sales reported by an equity method investment of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations reported by an equity method investee. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) reported by an equity method investment of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of revenue from sale of goods and services reduced by sales returns, allowances, and discounts reported by an equity method investment of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|